|
|
|
|
| LEADER |
01000naa a22002652 4500 |
| 001 |
NLM347092160 |
| 003 |
DE-627 |
| 005 |
20231226033014.0 |
| 007 |
cr uuu---uuuuu |
| 008 |
231226s2022 xx |||||o 00| ||eng c |
| 024 |
7 |
|
|a 10.1002/adma.202206851
|2 doi
|
| 028 |
5 |
2 |
|a pubmed24n1156.xml
|
| 035 |
|
|
|a (DE-627)NLM347092160
|
| 035 |
|
|
|a (NLM)36193764
|
| 040 |
|
|
|a DE-627
|b ger
|c DE-627
|e rakwb
|
| 041 |
|
|
|a eng
|
| 100 |
1 |
|
|a Zhang, Sijia
|e verfasserin
|4 aut
|
| 245 |
1 |
0 |
|a Biomineralized Two-Enzyme Nanoparticles Regulate Tumor Glycometabolism Inducing Tumor Cell Pyroptosis and Robust Antitumor Immunotherapy
|
| 264 |
|
1 |
|c 2022
|
| 336 |
|
|
|a Text
|b txt
|2 rdacontent
|
| 337 |
|
|
|a ƒaComputermedien
|b c
|2 rdamedia
|
| 338 |
|
|
|a ƒa Online-Ressource
|b cr
|2 rdacarrier
|
| 500 |
|
|
|a Date Completed 20.12.2022
|
| 500 |
|
|
|a Date Revised 22.12.2022
|
| 500 |
|
|
|a published: Print-Electronic
|
| 500 |
|
|
|a Citation Status MEDLINE
|
| 520 |
|
|
|a © 2022 Wiley-VCH GmbH.
|
| 520 |
|
|
|a Currently, immune checkpoint therapy combined with chemotherapy and radiotherapy is a useful strategy for improving immunotherapy's therapeutic efficacy. However, chemotherapy and radiotherapy cause serious side effects, so finding safe and effective methods to combine with immunotherapy is critical. In this work, regulating tumor glycometabolism is found to induce tumor cell pyroptosis and regulate the degree of expression of programmed death-ligand 1 (PD-L1). Therefore, how to treat tumors by regulating tumor glycometabolism in combination with anti-PD-L1 therapy is investigated here. First, the biomineralization-like method is used to construct nanoparticles with two-enzymatic activity by hybridizing nanozymes and glucose oxidase (GOx). It has the ability to self-amplify regulation of the glycometabolism of tumor cells. It can also induce tumor cell pyroptosis and increase the expression of PD-L1 in tumor cells. To treat tumors, nanoparticles are further combined with anti-PD-L1, which substantially inhibits tumor development and significantly increases the survival time of mice. Combination therapy also has a significant immunological memory effect, successfully preventing tumor recurrence and metastasis. This is thought to be the first study that combines tumor glycometabolism with immunocheckpoint blocking in cancer therapy. This innovative, safe, low-toxic, and highly effective anti-tumor strategy can have good prospects in clinical applications
|
| 650 |
|
4 |
|a Journal Article
|
| 650 |
|
4 |
|a antitumor immunotherapy
|
| 650 |
|
4 |
|a biomineralization
|
| 650 |
|
4 |
|a pyroptosis
|
| 650 |
|
4 |
|a tumor glycometabolism
|
| 650 |
|
4 |
|a two-enzyme nanoparticles
|
| 700 |
1 |
|
|a Zhang, Ying
|e verfasserin
|4 aut
|
| 700 |
1 |
|
|a Feng, Yuanji
|e verfasserin
|4 aut
|
| 700 |
1 |
|
|a Wu, Jiayan
|e verfasserin
|4 aut
|
| 700 |
1 |
|
|a Hu, Yingying
|e verfasserin
|4 aut
|
| 700 |
1 |
|
|a Lin, Lin
|e verfasserin
|4 aut
|
| 700 |
1 |
|
|a Xu, Caina
|e verfasserin
|4 aut
|
| 700 |
1 |
|
|a Chen, Jie
|e verfasserin
|4 aut
|
| 700 |
1 |
|
|a Tang, Zhaohui
|e verfasserin
|4 aut
|
| 700 |
1 |
|
|a Tian, Huayu
|e verfasserin
|4 aut
|
| 700 |
1 |
|
|a Chen, Xuesi
|e verfasserin
|4 aut
|
| 773 |
0 |
8 |
|i Enthalten in
|t Advanced materials (Deerfield Beach, Fla.)
|d 1998
|g 34(2022), 50 vom: 15. Dez., Seite e2206851
|w (DE-627)NLM098206397
|x 1521-4095
|7 nnns
|
| 773 |
1 |
8 |
|g volume:34
|g year:2022
|g number:50
|g day:15
|g month:12
|g pages:e2206851
|
| 856 |
4 |
0 |
|u http://dx.doi.org/10.1002/adma.202206851
|3 Volltext
|
| 912 |
|
|
|a GBV_USEFLAG_A
|
| 912 |
|
|
|a SYSFLAG_A
|
| 912 |
|
|
|a GBV_NLM
|
| 912 |
|
|
|a GBV_ILN_350
|
| 951 |
|
|
|a AR
|
| 952 |
|
|
|d 34
|j 2022
|e 50
|b 15
|c 12
|h e2206851
|